49,378 research outputs found

    Sampling: widening the perspective

    Get PDF

    Could dopamine agonists aid in drug development for anorexia nervosa?

    Get PDF
    Anorexia nervosa is a severe psychiatric disorder most commonly starting during the teenage-years and associated with food refusal and low body weight. Typically there is a loss of menses, intense fear of gaining weight, and an often delusional quality of altered body perception. Anorexia nervosa is also associated with a pattern of high cognitive rigidity, which may contribute to treatment resistance and relapse. The complex interplay of state and trait biological, psychological, and social factors has complicated identifying neurobiological mechanisms that contribute to the illness. The dopamine D1 and D2 neurotransmitter receptors are involved in motivational aspects of food approach, fear extinction, and cognitive flexibility. They could therefore be important targets to improve core and associated behaviors in anorexia nervosa. Treatment with dopamine antagonists has shown little benefit, and it is possible that antagonists over time increase an already hypersensitive dopamine pathway activity in anorexia nervosa. On the contrary, application of dopamine receptor agonists could reduce circuit responsiveness, facilitate fear extinction, and improve cognitive flexibility in anorexia nervosa, as they may be particularly effective during underweight and low gonadal hormone states. This article provides evidence that the dopamine receptor system could be a key factor in the pathophysiology of anorexia nervosa and dopamine agonists could be helpful in reducing core symptoms of the disorder. This review is a theoretical approach that primarily focuses on dopamine receptor function as this system has been mechanistically better described than other neurotransmitters that are altered in anorexia nervosa. However, those proposed dopamine mechanisms in anorexia nervosa also warrant further study with respect to their interaction with other neurotransmitter systems, such as serotonin pathways

    Hyper-Kamiokande Physics Opportunities

    Get PDF
    We propose the Hyper-Kamiokande (Hyper-K) detector as a next generation un- derground water Cherenkov detector. It will serve as a far detector of a long base- line neutrino oscillation experiment envisioned for the upgraded J-PARC beam, and as a detector capable of observing, far beyond the sensitivity of the Super-Kamiokande (Super-K) detector, proton decays, atmospheric neutrinos, and neutrinos from astro- physical origins. The current baseline design of Hyper-K is based on the highly suc- cessful Super-K detector, taking full advantage of a well-proven technology. Hyper-K consists of two cylindrical tanks lying side-by-side, the outer dimensions of each tank being 48(W) x54(H) x 250(L) m3. The total (fiducial) mass of the detector is 0.99 (0.56) million metric tons, which is about 20 (25) times larger than that of Super-K. This set of three one- page whitepapers prepared for the US Snowmass process describes the opportunities for future physics discoveries at the Hyper-K facility with beam, atmospheric and astrophysical neutrinos

    Subunit composition of minK potassium channels.

    Get PDF
    Expression of minK protein in Xenopus oocytes induces a slowly activating, voltage-dependent, potassium-selective current. Point mutations in minK that alter current gating kinetics, ion selectivity, pharmacology, and response to protein kinase C all support the notion that minK is a structural protein for a channel-type transporter. Yet, minK has just 130 amino acids and a single transmembrane domain. Though larger cloned potassium channels form functional channels through tetrameric subunit association, the subunit composition of minK is unknown. Subunit stoichiometry was determined by coexpression of wild-type minK and a dominant lethal point mutant of minK, which reaches the plasma membrane but passes no current. The results support a model for complete minK potassium channels in which just two minK monomers are present, with other, as yet unidentified, non-minK subunits

    Uncertain Flow Visualization using LIC

    Get PDF
    In this paper we look at the Line Integral Convolution method for flow visualization and ways in which this can be applied to the visualization of two dimensional, steady flow fields in the presence of uncertainty. To achieve this, we start by studying the method and reviewing the history of modifications other authors have made to it in order to improve its efficiency or capabilities, and using these as a base for the visualization of uncertain flow fields. Finally, we apply our methodology to a case study from the field of oceanography

    The onset of instability in unsteady boundary-layer separation

    Get PDF
    The process of unsteady two-dimensional boundary-layer separation at high Reynolds number is considered. Solutions of the unsteady non-interactive boundary-layer equations are known to develop a generic separation singularity in regions where the pressure gradient is prescribed and adverse. As the boundary layer starts to separate from the surface, however, the external pressure distribution is altered through viscous-inviscid interaction just prior to the formation of the separation singularity; hitherto this has been referred to as the first interactive stage. A numerical solution of this stage is obtained here in Lagrangian coordinates. The solution is shown to exhibit a high-frequency inviscid instability resulting in an immediate finite-time breakdown of this stage. The presence of the instability is confirmed through a linear stability analysis. The implications for the theoretical description of unsteady boundary-layer separation are discussed, and it is suggested that the onset of interaction may occur much sooner than previously thought

    Role of insulin-like growth factor binding protein-3 in 1, 25-dihydroxyvitamin-d 3 -induced breast cancer cell apoptosis.

    Get PDF
    Insulin-like growth factor I (IGF-I) is implicated in breast cancer development and 1, 25-dihydroxyvitamin D3 (1, 25-D3) has been shown to attenuate prosurvival effects of IGF-I on breast cancer cells. In this study the role of IGF binding protein-3 (IGFBP-3) in 1, 25-D3-induced apoptosis was investigated using parental MCF-7 breast cancer cells and MCF-7/VD(R) cells, which are resistant to the growth inhibitory effects of 1, 25-D3. Treatment with 1, 25-D3 increased IGFBP-3 mRNA expression in both cell lines but increases in intracellular IGFBP-3 protein and its secretion were observed only in MCF-7. 1, 25-D3-induced apoptosis was not associated with activation of any caspase but PARP-1 cleavage was detected in parental cells. IGFBP-3 treatment alone produced cleavage of caspases 7, 8, and 9 and PARP-1 in MCF-7 cells. IGFBP-3 failed to activate caspases in MCF-7/VD(R) cells; however PARP-1 cleavage was detected. 1, 25-D3 treatment inhibited IGF-I/Akt survival signalling in MCF-7 but not in MCF-7/VD(R) cells. In contrast, IGFBP-3 treatment was effective in inhibiting IGF-I/Akt pathways in both breast cancer lines. These results suggest a role for IGFBP-3 in 1, 25-D3 apoptotic signalling and that impaired secretion of IGFBP-3 may be involved in acquired resistance to vitamin D in breast cancer
    • …
    corecore